Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4
Publication
, Conference
Murlidharan, G; Sommerville, L; Ghashghaei, T; Asokan, A
Published in: MOLECULAR THERAPY
June 1, 2013
Duke Scholars
Published In
MOLECULAR THERAPY
ISSN
1525-0016
Publication Date
June 1, 2013
Volume
21
Start / End Page
S1 / S1
Location
Salt Lake City, UT
Publisher
NATURE PUBLISHING GROUP
Conference Name
16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Murlidharan, G., Sommerville, L., Ghashghaei, T., & Asokan, A. (2013). Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4. In MOLECULAR THERAPY (Vol. 21, pp. S1–S1). Salt Lake City, UT: NATURE PUBLISHING GROUP.
Murlidharan, Giridhar, Laura Sommerville, Troy Ghashghaei, and Aravind Asokan. “Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4.” In MOLECULAR THERAPY, 21:S1–S1. NATURE PUBLISHING GROUP, 2013.
Murlidharan G, Sommerville L, Ghashghaei T, Asokan A. Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4. In: MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2013. p. S1–S1.
Murlidharan, Giridhar, et al. “Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4.” MOLECULAR THERAPY, vol. 21, NATURE PUBLISHING GROUP, 2013, pp. S1–S1.
Murlidharan G, Sommerville L, Ghashghaei T, Asokan A. Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4. MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2013. p. S1–S1.
Published In
MOLECULAR THERAPY
ISSN
1525-0016
Publication Date
June 1, 2013
Volume
21
Start / End Page
S1 / S1
Location
Salt Lake City, UT
Publisher
NATURE PUBLISHING GROUP
Conference Name
16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences